$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-K Financial Statement

#000072137117000083 Filed on August 10, 2017

Income Statement

Concept	2016 Q2	2016 Q1	2015 Q4
Revenue	$31.38B	$30.66B	$31.45B
YoY Change	13.93%	20.84%	23.14%
Cost Of Revenue	$29.72B	$28.97B	$29.84B
YoY Change	13.91%	21.14%	23.89%
Gross Profit	$1.665B	$1.689B	$1.609B
YoY Change	14.2%	15.76%	10.66%
Gross Profit Margin	5.31%	5.51%	5.12%
Selling, General & Admin	$970.0M	$914.0M	$922.0M
YoY Change	14.52%	13.82%	13.13%
% of Gross Profit	58.26%	54.11%	57.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$176.0M	$159.0M	$169.0M
YoY Change	53.04%	37.07%	50.89%
% of Gross Profit	10.57%	9.41%	10.5%
Operating Expenses	$970.0M	$914.0M	$922.0M
YoY Change	14.52%	13.82%	13.13%
Operating Profit	$695.0M	$656.0M	$563.0M
YoY Change	13.75%	11.0%	3.11%
Interest Expense	-$44.00M	$44.00M	$45.00M
YoY Change	22.22%	25.71%	25.0%
% of Operating Profit	-6.33%	6.71%	7.99%
Other Income/Expense, Net	$0.00	$0.00	$2.000M
YoY Change	-100.0%	-100.0%	100.0%
Pretax Income	$576.0M	$612.0M	$520.0M
YoY Change	10.13%	9.68%	15.3%
Income Tax	$241.0M	$226.0M	$194.0M
% Of Pretax Income	41.84%	36.93%	37.31%
Net Earnings	$333.0M	$386.0M	$326.0M
YoY Change	12.88%	5.75%	12.8%
Net Earnings / Revenue	1.06%	1.26%	1.04%
Basic Earnings Per Share		$1.18	$0.99
Diluted Earnings Per Share	$1.015M	$1.17	$0.98
COMMON SHARES
Basic Shares Outstanding	325.8M shares	328.0M shares	329.0M shares
Diluted Shares Outstanding		331.0M shares	332.0M shares

Balance Sheet

Concept	2016 Q2	2016 Q1	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.356B	$2.598B	$2.324B
YoY Change	-48.96%	-18.38%	-19.33%
Cash & Equivalents	$2.356B	$2.598B	$2.324B
Short-Term Investments
Other Short-Term Assets	$1.580B	$1.491B	$1.518B
YoY Change	12.7%	25.29%	25.14%
Inventory	$10.62B	$10.91B	$11.01B
Prepaid Expenses
Receivables	$7.405B	$7.292B	$6.980B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$21.96B	$22.29B	$21.83B
YoY Change	0.94%	13.55%	13.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.796B	$1.683B	$1.651B
YoY Change	19.26%	19.62%	16.68%
Goodwill	$7.167B	$6.888B	$6.799B
YoY Change	41.36%	36.26%	37.94%
Intangibles	$1.986B	$2.262B	$2.314B
YoY Change	109.49%	131.29%	144.35%
Long-Term Investments
YoY Change
Other Assets	$944.0M	$931.0M	$914.0M
YoY Change	9.01%	13.95%	13.97%
Total Long-Term Assets	$12.17B	$11.76B	$11.68B
YoY Change	45.01%	42.47%	44.3%
TOTAL ASSETS
Total Short-Term Assets	$21.96B	$22.29B	$21.83B
Total Long-Term Assets	$12.17B	$11.76B	$11.68B
Total Assets	$34.12B	$34.06B	$33.51B
YoY Change	13.2%	22.11%	22.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.31B	$17.34B	$16.92B
YoY Change	20.45%	25.19%	24.39%
Accrued Expenses	$1.808B	$1.694B	$1.606B
YoY Change	-30.3%	-25.08%	-25.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$587.0M	$351.0M	$354.0M
YoY Change	108.9%	24.03%	31.11%
Total Short-Term Liabilities	$19.70B	$19.39B	$18.88B
YoY Change	14.26%	18.24%	17.77%
LONG-TERM LIABILITIES
Long-Term Debt	$4.952B	$5.195B	$5.171B
YoY Change	-4.97%	39.65%	39.53%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.952B	$5.195B	$5.171B
YoY Change	-4.97%	39.65%	39.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.70B	$19.39B	$18.88B
Total Long-Term Liabilities	$4.952B	$5.195B	$5.171B
Total Liabilities	$27.57B	$27.34B	$26.80B
YoY Change	15.41%	27.06%	26.71%
SHAREHOLDERS EQUITY
Retained Earnings	$6.419B	$6.231B	$5.972B
YoY Change	16.27%	16.4%	17.1%
Common Stock	$3.010B	$2.995B	$2.973B
YoY Change	0.23%	0.1%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.759B	$2.429B	$2.137B
YoY Change	22.9%	26.31%	8.48%
Treasury Stock Shares	42.00M shares	38.00M shares	34.00M shares
Shareholders Equity	$6.554B	$6.713B	$6.711B
YoY Change
Total Liabilities & Shareholders Equity	$34.12B	$34.06B	$33.51B
YoY Change	13.2%	22.11%	22.97%

Cashflow Statement

Concept	2016 Q2	2016 Q1	2015 Q4
OPERATING ACTIVITIES
Net Income	$333.0M	$386.0M	$326.0M
YoY Change	12.88%	5.75%	12.8%
Depreciation, Depletion And Amortization	$176.0M	$159.0M	$169.0M
YoY Change	53.04%	37.07%	50.89%
Cash From Operating Activities	$641.0M	$919.0M	$1.463B
YoY Change	-26.15%	39.67%	53.52%
INVESTING ACTIVITIES
Capital Expenditures	-$181.0M	-$109.0M	-$92.00M
YoY Change	12.42%	94.64%	95.74%
Acquisitions
YoY Change
Other Investing Activities	-$218.0M	-$101.0M	-$1.901B
YoY Change	-27.81%	-56.09%	-6889.29%
Cash From Investing Activities	-$399.0M	-$210.0M	-$1.993B
YoY Change	-13.82%	-26.57%	10389.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-479.0M	-438.0M	-110.0M
YoY Change	-146.6%	525.71%	-78.93%
NET CHANGE
Cash From Operating Activities	641.0M	919.0M	1.463B
Cash From Investing Activities	-399.0M	-210.0M	-1.993B
Cash From Financing Activities	-479.0M	-438.0M	-110.0M
Net Change In Cash	-237.0M	271.0M	-640.0M
YoY Change	-116.54%	-10.26%	-255.34%
FREE CASH FLOW
Cash From Operating Activities	$641.0M	$919.0M	$1.463B
Capital Expenditures	-$181.0M	-$109.0M	-$92.00M
Free Cash Flow	$822.0M	$1.028B	$1.555B
YoY Change	-20.12%	43.98%	55.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	459000000	USD
CY2015	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	281000000	USD
CY2017	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	527000000	USD
CY2017	cah	Concentration Risk Largest Group Purchasing Organizations ConcentrationRiskLargestGroupPurchasingOrganizations	2	organization
CY2016Q2	cah	Deferred Tax Assets Relatedtouncertaintaxpositions DeferredTaxAssetsRelatedtouncertaintaxpositions	95000000	USD
CY2017Q2	cah	Deferred Tax Assets Relatedtouncertaintaxpositions DeferredTaxAssetsRelatedtouncertaintaxpositions	51000000	USD
CY2015	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	10000000	USD
CY2016	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	10000000	USD
CY2017	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	5000000	USD
CY2014Q4	cah	Fairvalueadjustmentduetoterminationofinterestrateswap Fairvalueadjustmentduetoterminationofinterestrateswap	22000000	USD
CY2016	cah	Fairvalueadjustmentduetoterminationofinterestrateswap Fairvalueadjustmentduetoterminationofinterestrateswap	22000000	USD
CY2016Q2	cah	Indemnification Receivable IndemnificationReceivable	172000000	USD
CY2017Q2	cah	Indemnification Receivable IndemnificationReceivable	142000000	USD
CY2017Q2	cah	Loss Contingency Accrual Netof Insurance Recoveries LossContingencyAccrualNetofInsuranceRecoveries	98000000	USD
CY2016	cah	Net Earnings Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	1430000000	USD
CY2017	cah	Net Earnings Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetEarningsIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	1290000000	USD
CY2015	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	72000000	USD
CY2016	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	6000000	USD
CY2017	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	26000000	USD
CY2015	cah	Paymentof Contingent Consideration PaymentofContingentConsideration	7000000	USD
CY2016	cah	Paymentof Contingent Consideration PaymentofContingentConsideration	25000000	USD
CY2017	cah	Paymentof Contingent Consideration PaymentofContingentConsideration	3000000	USD
CY2015	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	53000000	USD
CY2016	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	13000000	USD
CY2017	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	3000000	USD
CY2015	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	206000000	USD
CY2016	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	136000000	USD
CY2017	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	228000000	USD
CY2015	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	26000000	USD
CY2016	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	34000000	USD
CY2017	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	17000000	USD
CY2015	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	342000000	USD
CY2016	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	200000000	USD
CY2017	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	194000000	USD
CY2016Q2	cah	Revenue Recognition Reservefor Sales Returnsand Allowances RevenueRecognitionReserveforSalesReturnsandAllowances	386000000	USD
CY2017Q2	cah	Revenue Recognition Reservefor Sales Returnsand Allowances RevenueRecognitionReserveforSalesReturnsandAllowances	347000000	USD
CY2016Q2	cah	Vendor Reserves VendorReserves	62000000	USD
CY2017Q2	cah	Vendor Reserves VendorReserves	50000000	USD
CY2017	cah	Weighted Average Effective Maturity Period WeightedAverageEffectiveMaturityPeriod	P7M
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000721371
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	316453664	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q4	dei	Entity Public Float EntityPublicFloat	22624332824	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	CARDINAL HEALTH INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2017	dei	Trading Symbol TradingSymbol	cah
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17306000000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17906000000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2680000000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2748000000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-116000000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-125000000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110000000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	111000000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	96000000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	191000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	355000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	395000000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2015Q2	us-gaap	Assets Assets	30142000000	USD
CY2016Q2	us-gaap	Assets Assets	34122000000	USD
CY2017Q2	us-gaap	Assets Assets	40112000000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	21956000000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	28345000000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	200000000	USD
CY2017Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	65000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	113000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	65000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	87000000	USD
CY2017Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	0	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	8000000	USD
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-16000000	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5000000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2865000000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4616000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2356000000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6879000000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1751000000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2260000000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4523000000	USD
CY2017Q2	us-gaap	Commercial Paper CommercialPaper	855000000	USD
CY2015	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.37
CY2016	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.55
CY2017	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.80
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364000000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	3010000000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	2697000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1122000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1334000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1279000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1122000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1338000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1285000000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	96819000000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	115003000000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	123432000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	424000000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	633000000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	273000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	29000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	73000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	56000000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	536000000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	758000000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	339000000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	83000000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	52000000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	10000000	USD
CY2016Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	5539000000	USD
CY2017Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	10395000000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	196000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	96000000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	258000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-21000000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-4000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	219000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	87000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	291000000	USD
CY2016Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2130000000	USD
CY2017Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2331000000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	24000000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	12000000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	37000000	USD
CY2016Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2781000000	USD
CY2017Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2877000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	567000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	692000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	42000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	73000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	474000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	455000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	46000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	43000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	193000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	378000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	56000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	53000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	133000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	125000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	44000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	42000000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	93000000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	237000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1656000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1876000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1351000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1578000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	607000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	570000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1698000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1949000000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	172000000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	183000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	91000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	49000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	84000000	USD
CY2015	us-gaap	Depreciation Depreciation	254000000	USD
CY2016	us-gaap	Depreciation Depreciation	277000000	USD
CY2017	us-gaap	Depreciation Depreciation	314000000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	451000000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	641000000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	717000000	USD
CY2016Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	35000000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	3000000	USD
CY2016Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	16000000	USD
CY2017Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	24000000	USD
CY2015	us-gaap	Dividends Cash DividendsCash	471000000	USD
CY2016	us-gaap	Dividends Cash DividendsCash	529000000	USD
CY2017	us-gaap	Dividends Cash DividendsCash	580000000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.66
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.36
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.06
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.62
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.32
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.03
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-12000000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2000000	USD
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.384
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.371
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.327
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.024
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.006
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.002
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.007
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.010
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.002
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.010
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.033
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.041
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.015
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.010
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	38000000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	38000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	34000000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	52000000	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	33000000	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	34000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	370000000	USD
CY2014Q4	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-37000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1075000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1466000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	195000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	219000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	270000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	301000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3262000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3391000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2187000000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1925000000	USD
CY2017	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
CY2015	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	19000000	USD
CY2016	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-21000000	USD
CY2017	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-18000000	USD
CY2015	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-5000000	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	69000000	USD
CY2017	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-48000000	USD
CY2015	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	5000000	USD
CY2016	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2014Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-60000000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-60000000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q2	us-gaap	Goodwill Goodwill	5070000000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	7167000000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	7221000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2120000000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	64000000	USD
CY2016	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-23000000	USD
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	10000000	USD
CY2017Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	829000000	USD
CY2015	us-gaap	Gross Profit GrossProfit	5712000000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	1579000000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	1609000000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	1689000000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	1665000000	USD
CY2016	us-gaap	Gross Profit GrossProfit	6543000000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	1590000000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	1602000000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	1728000000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	1623000000	USD
CY2017	us-gaap	Gross Profit GrossProfit	6544000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1212000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1427000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1288000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1733000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2050000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1772000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	234000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	226000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	152000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1967000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2276000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1924000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1212000000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	384000000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	326000000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	386000000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	335000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1431000000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	310000000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	324000000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	382000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1294000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.65
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.17
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.99
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.18
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.03
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.36
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.97
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.02
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.21
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.87
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.06
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.61
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.15
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.98
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.17
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.32
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.96
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.20
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.86
CY2017	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.03
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3000000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2015Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016Q1	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	12000000	USD
CY2016Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2017Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	755000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	845000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	630000000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	529000000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	635000000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	686000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1948000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2815000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	564000000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	779000000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1179000000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	673000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-153000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	147000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	520000000	USD
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	870000000	USD
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	866000000	USD
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	665000000	USD
CY2016Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	72000000	USD
CY2017Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	61000000	USD
CY2016Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3334000000	USD
CY2017Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3452000000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2259000000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1986000000	USD
CY2016Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9426000000	USD
CY2017Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9207000000	USD
CY2015	us-gaap	Interest Expense InterestExpense	141000000	USD
CY2016	us-gaap	Interest Expense InterestExpense	178000000	USD
CY2017	us-gaap	Interest Expense InterestExpense	201000000	USD
CY2015	us-gaap	Interest Paid Net InterestPaidNet	150000000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	174000000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	200000000	USD
CY2016Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	9000000	USD
CY2017Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	46000000	USD
CY2015Q4	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	39000000	USD
CY2016Q2	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	-51000000	USD
CY2016Q4	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	-9000000	USD
CY2017Q1	us-gaap	Inventory Lifo Reserve Effect On Income Net InventoryLIFOReserveEffectOnIncomeNet	9000000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	10615000000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	11301000000	USD
CY2016Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	79000000	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	76000000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	104000000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	126000000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	159000000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34122000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40112000000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	19701000000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	21221000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4952000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9068000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	587000000	USD
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1327000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	5357000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1327000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1738000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	521000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	454000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	998000000	USD
CY2017Q2	us-gaap	Longterm Debt Weighted Average Interest Rate LongtermDebtWeightedAverageInterestRate	0.03
CY2017	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	4000000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	17000000	USD
CY2017Q2	us-gaap	Minority Interest MinorityInterest	20000000	USD
CY2016	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	7000000	USD
CY2017	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	1000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1139000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3746000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-849000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4080000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-405000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2540000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2971000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1184000000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1215000000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	383000000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	326000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	386000000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	333000000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	1427000000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	309000000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	324000000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	381000000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	274000000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
CY2015Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2000000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4000000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4000000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6000000	USD
CY2016Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	31000000	USD
CY2017Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	53000000	USD
CY2016Q2	us-gaap	Notes Receivable Net NotesReceivableNet	145000000	USD
CY2017Q2	us-gaap	Notes Receivable Net NotesReceivableNet	171000000	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	2161000000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	2459000000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	2120000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	110000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	41000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	59000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	77000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	94000000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	107000000	USD
CY2017Q2	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	223000000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1808000000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1988000000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1580000000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2117000000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	944000000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	681000000	USD
CY2016Q2	us-gaap	Other Borrowings OtherBorrowings	330000000	USD
CY2017Q2	us-gaap	Other Borrowings OtherBorrowings	388000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	11000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-11000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	16000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-104000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-82000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-25000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-93000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-93000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-93000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-93000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-9000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-6000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-9000000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000000	USD
CY2015	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	0	USD
CY2016	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	0	USD
CY2017	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-14000000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1036000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	651000000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	600000000	USD
CY2016	us-gaap	Payments For Restructuring PaymentsForRestructuring	25000000	USD
CY2017	us-gaap	Payments For Restructuring PaymentsForRestructuring	19000000	USD
CY2014Q4	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	80000000	USD
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	460000000	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	512000000	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	577000000	USD
CY2015	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	0	USD
CY2016	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	10000000	USD
CY2017	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	12000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	503000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3614000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	132000000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	300000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	465000000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	387000000	USD
CY2016Q2	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.58
CY2017Q2	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.56
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2672000000	USD
CY2016	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2017	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	5171000000	USD
CY2015	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	71000000	USD
CY2016	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	80000000	USD
CY2017	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	1000000	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	37000000	USD
CY2016	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	50000000	USD
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	77000000	USD
CY2015	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-12000000	USD
CY2016	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	26000000	USD
CY2017	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	3000000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	1215000000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	384000000	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	326000000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	386000000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	335000000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	1431000000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	310000000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	324000000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	382000000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	278000000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	1294000000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4476000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4627000000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1506000000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1796000000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1879000000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	52000000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	73000000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	63000000	USD
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	7405000000	USD
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	8048000000	USD
CY2016Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	117000000	USD
CY2017Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	118000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1221000000	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	6000000	USD
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	310000000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	44000000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	25000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	56000000	USD
CY2016	us-gaap	Restructuring Costs RestructuringCosts	19000000	USD
CY2017	us-gaap	Restructuring Costs RestructuringCosts	44000000	USD
CY2015Q2	us-gaap	Restructuring Reserve RestructuringReserve	22000000	USD
CY2016Q2	us-gaap	Restructuring Reserve RestructuringReserve	16000000	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	41000000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6419000000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4967000000	USD
CY2015	us-gaap	Revenues Revenues	102531000000	USD
CY2015Q3	us-gaap	Revenues Revenues	28055000000	USD
CY2015Q4	us-gaap	Revenues Revenues	31445000000	USD
CY2016Q1	us-gaap	Revenues Revenues	30662000000	USD
CY2016Q2	us-gaap	Revenues Revenues	31384000000	USD
CY2016	us-gaap	Revenues Revenues	121546000000	USD
CY2016Q3	us-gaap	Revenues Revenues	32039000000	USD
CY2016Q4	us-gaap	Revenues Revenues	33150000000	USD
CY2017Q1	us-gaap	Revenues Revenues	31821000000	USD
CY2017Q2	us-gaap	Revenues Revenues	32966000000	USD
CY2017	us-gaap	Revenues Revenues	129976000000	USD
CY2015	us-gaap	Sales Returns And Allowances Goods SalesReturnsAndAllowancesGoods	2000000000	USD
CY2016	us-gaap	Sales Returns And Allowances Goods SalesReturnsAndAllowancesGoods	2200000000	USD
CY2017	us-gaap	Sales Returns And Allowances Goods SalesReturnsAndAllowancesGoods	2300000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3240000000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	842000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3775000000	USD
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	51000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	110000000	USD
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	922000000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	914000000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	970000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3648000000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	920000000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	910000000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	960000000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	983000000	USD
CY2015	us-gaap	Severance Costs1 SeveranceCosts1	34000000	USD
CY2016	us-gaap	Severance Costs1 SeveranceCosts1	15000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	111000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	96000000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4000000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.86
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8000000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7000000	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.50
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	54.09
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.44
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	39.06
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	37.79
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	84.11
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.09
CY2015	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	454000000	USD
CY2016	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	504000000	USD
CY2017	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	496000000	USD
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000000	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000000	shares
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	237000000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	144000000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	156000000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	6554000000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	6808000000	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6401000000	USD
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6256000000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6571000000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6828000000	USD
CY2015	us-gaap	Stockholders Equity Other StockholdersEquityOther	-3000000	USD
CY2016	us-gaap	Stockholders Equity Other StockholdersEquityOther	-21000000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	USD
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	42000000	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	11000000	shares
CY2017	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	37000000	shares
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2759000000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	731000000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1036000000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	651000000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	600000000	USD
CY2017Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	700000000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	510000000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	542000000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	527000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	417000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	42000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	48000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	8000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	10000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	30000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	154000000	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	169000000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	145000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	99000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	24000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	9000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	12000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	15000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	22000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	29000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	69000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	42000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	23000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2015Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	357000000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	355000000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	268000000	USD
CY2014Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	429000000	USD
CY2015Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	455000000	USD
CY2016Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	541000000	USD
CY2017Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	494000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2047000000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2285000000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	2347000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	5000000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	2000000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2026000000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2201000000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	2395000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	1000000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	2000000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Recoveries ValuationAllowancesAndReservesRecoveries	1000000	USD
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2017	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	327000000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	335000000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	330000000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	320000000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	332000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	317000000	shares
CY2014Q4	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	2000000	USD
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We maintain cash depository accounts with major banks, and we invest in high quality, short-term liquid instruments, and in marketable securities. Our short-term liquid instruments mature within three months and we have not historically incurred any related losses. Investments in marketable debt securities consist of a portfolio of high-grade instruments. Such investments are made only in instruments issued by highly-rated institutions, whose financial condition we monitor.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our trade receivables and finance notes and related accrued interest are exposed to a concentration of credit risk with customers in the retail and healthcare sectors. Credit risk can be affected by changes in reimbursement and other economic pressures impacting the healthcare industry. Such credit risk is limited due to supporting collateral and the diversity of the customer base, including its wide geographic dispersion. We perform regular credit evaluations of our customers’ financial conditions and maintain reserves for losses through the established allowance for doubtful accounts. Historically, such losses have been within our expectations. Refer to the "Receivables and Allowance for Doubtful Accounts" section within this Note for additional information on the accounting treatment of reserves for allowance for doubtful accounts. </font></div></div>
CY2017	us-gaap	Derivatives Methods Of Accounting Hedging Derivatives DerivativesMethodsOfAccountingHedgingDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Interest Rate, Currency and Commodity Risk</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">All derivative instruments are recognized at fair value on the consolidated balance sheets and all changes in fair value are recognized in net earnings or shareholders’ equity through AOCI, net of tax.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">For contracts that qualify for hedge accounting treatment, the hedge contracts must be effective at reducing the risk associated with the exposure being hedged and must be designated as a hedge at the inception of the contract. Hedge effectiveness is assessed periodically. Any contract not designated as a hedge, or so designated but ineffective, is adjusted to fair value and recognized immediately in net earnings. If a fair value or cash flow hedge ceases to qualify for hedge accounting treatment, the contract continues to be carried on the balance sheet at fair value until settled and future adjustments to the contract’s fair value are recognized immediately in net earnings. If a forecasted transaction is probable not to occur, amounts previously deferred in AOCI are recognized immediately in net earnings. See </font><a style="font-family:Arial Narrow;font-size:10pt;" href="#sC8874F85C6C55DE49E64F67E0CE945F9"><font style="font-family:Arial Narrow;font-size:10pt;">Note 11</font></a><font style="font-family:Arial Narrow;font-size:10pt;"> for additional information regarding our derivative instruments, including the accounting treatment for instruments designated as fair value, cash flow and economic hedges.</font></div></div>
CY2017	us-gaap	Revenue Recognition Sales Returns RevenueRecognitionSalesReturns	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Sales Returns and Allowances</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Revenue is recorded net of sales returns and allowances. Our customer return policies generally require that the product be physically returned, subject to restocking fees, in a condition suitable to be added back to inventory and resold at full value, or returned to vendors for credit (“merchantable product”). Product returns are generally consistent throughout the year and typically are not specific to any particular product or customer.</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">We accrue for estimated sales returns and allowances at the time of sale based upon historical customer return trends, margin rates and processing costs. Our accrual for sales returns is reflected as a reduction of revenue and cost of products sold for the sales price and cost, respectively. At </font><font style="font-family:Arial Narrow;font-size:10pt;">June 30, 2017</font><font style="font-family:Arial Narrow;font-size:10pt;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;">, the accrual for estimated sales returns and allowances was </font><font style="font-family:Arial Narrow;font-size:10pt;">$347 million</font><font style="font-family:Arial Narrow;font-size:10pt;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;">$386 million</font><font style="font-family:Arial Narrow;font-size:10pt;">, respectively, the impact of which is reflected in trade receivables, net and inventories, net in the consolidated balance sheets. Sales returns and allowances were </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.3 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">, </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.2 billion</font><font style="font-family:Arial Narrow;font-size:10pt;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial Narrow;font-size:10pt;">, for fiscal </font><font style="font-family:Arial Narrow;font-size:10pt;">2017</font><font style="font-family:Arial Narrow;font-size:10pt;">, </font><font style="font-family:Arial Narrow;font-size:10pt;">2016</font><font style="font-family:Arial Narrow;font-size:10pt;"> and </font><font style="font-family:Arial Narrow;font-size:10pt;">2015</font><font style="font-family:Arial Narrow;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Third-Party Returns</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Since we generally do not accept non-merchantable product returns from our customers, many of our customers return non-merchantable pharmaceutical products to the manufacturer through third parties. Since our customers generally do not have a direct relationship with manufacturers, our vendors pass the value of such returns to us (usually in the form of an accounts payable deduction) for distribution to customers. We, in turn, pass the value received, less an administrative fee, to our customer. In certain instances, we pass the estimated value of the return to our customer prior to our receipt of the value from the vendor. Although we believe we have satisfactory protections, we could be subject to claims from customers or vendors if our administration of this overall process was deficient in some respect or our contractual terms with vendors are in conflict with our contractual terms with our customers. We have maintained reserves for some of these situations based on their nature and our historical experience with their resolution.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation, business combinations, goodwill and other intangible asset impairment, vendor reserves, loss contingencies, self-insurance accruals, income taxes and share-based compensation. Actual amounts could ultimately differ from these estimated amounts.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:12pt;"><font style="font-family:Arial Narrow;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><font style="font-family:Arial Narrow;font-size:10pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in accordance with GAAP requires us to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates, judgments and assumptions are used in the accounting and disclosure related to, among other items, allowance for doubtful accounts, inventory valuation, business combinations, goodwill and other intangible asset impairment, vendor reserves, loss contingencies, self-insurance accruals, income taxes and share-based compensation. Actual amounts could ultimately differ from these estimated amounts.</font></div></div>

Files In Submission

Name	View Source	Status
0000721371-17-000083-index-headers.html	Edgar Link	pending
0000721371-17-000083-index.html	Edgar Link	pending
0000721371-17-000083.txt	Edgar Link	pending
0000721371-17-000083-xbrl.zip	Edgar Link	pending
a1710kprintready.pdf	Edgar Link	pending
a17q4_10kx063017xexhibit1022.htm	Edgar Link	pending
a17q4_10kx063017xexhibit1023.htm	Edgar Link	pending
a17q4_10kx063017xexhibit1024.htm	Edgar Link	pending
a17q4_10kx063017xexhibit1025.htm	Edgar Link	pending
a17q4_10kx063017xexhibit121.htm	Edgar Link	pending
a17q4_10kx063017xexhibit211.htm	Edgar Link	pending
a17q4_10kx063017xexhibit222.htm	Edgar Link	pending
a17q4_10kx063017xexhibit231.htm	Edgar Link	pending
a17q4_10kx063017xexhibit311.htm	Edgar Link	pending
a17q4_10kx063017xexhibit312.htm	Edgar Link	pending
a17q4_10kx063017xexhibit321.htm	Edgar Link	pending
a17q4_10kx063017xexhibit991.htm	Edgar Link	pending
a17q4_10kx63017xform10-k.htm	Edgar Link	pending
a17q4_10kx630xchart-04882.jpg	Edgar Link	pending
a17q4_10kx630xchart-05600.jpg	Edgar Link	pending
a17q4_10kx630xchart-05773.jpg	Edgar Link	pending
a17q4_10kx630xchart-06441.jpg	Edgar Link	pending
a17q4_10kx630xchart-07090.jpg	Edgar Link	pending
a17q4_10kx630xchart-08072.jpg	Edgar Link	pending
a17q4_10kx630xchart-08890.jpg	Edgar Link	pending
a17q4_10kx630xchart-09920.jpg	Edgar Link	pending
a17q4_10kx630xchart-10900.jpg	Edgar Link	pending
a17q4_10kx630xchart-11991.jpg	Edgar Link	pending
cah-20170630.xml	Edgar Link	completed
cah-20170630.xsd	Edgar Link	pending
cah-20170630_cal.xml	Edgar Link	unprocessable
cah-20170630_def.xml	Edgar Link	unprocessable
cah-20170630_lab.xml	Edgar Link	unprocessable
cah-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
marketforregistrant.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2016 Q2 Form 10-K Financial Statement

#000072137117000083 Filed on August 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2016 Q2 Form 10-K Financial Statement

#000072137117000083 Filed on August 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah